(Q35903121)

11 August 2017

1 reference

title

Pleural mesothelioma: little evidence, still time to do trials (English)

1 reference

11 August 2017

Tom Treasure

1

1 reference

11 August 2017

Artyom Sedrakyan

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

364

1 reference

11 August 2017

issue

9440

1 reference

11 August 2017

page(s)

1183-1185

1 reference

Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Changing trends in US mesothelioma incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Asbestos and mesothelioma in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Epidemiology of malignant mesothelioma in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

The European mesothelioma epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Pleurodesis for malignant pleural effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Surgical treatment of malignant pleural mesothelioma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

The management of malignant pleural mesothelioma; single centre experience in 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Mesothelioma--VATS biopsy and lung mobilization improves diagnosis and palliation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Trimodality management of malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917108-0

7 January 2021

10.1016/S0140-6736(04)17108-0

Identifiers

DOI

1 reference

11 August 2017

1 reference